
India recorded a 38% reduction in tuberculosis mortality since 2015, compared with a 35% global decline, the World Health Organization’s Global Tuberculosis Report 2026 said on Thursday, 12 November. The country also achieved a 94% treatment success rate among drug-susceptible TB patients, with the estimated mortality rate falling from 280 per million people in 2015 to 180 per million in 2025.

Globally, an estimated 10.6 million people fell ill with TB in 2025, a decline of 75,000 from the previous year. India accounted for about 25% of global cases, followed by Indonesia, the Philippines, China, Pakistan, Nigeria, the Democratic Republic of the Congo and Bangladesh. Eight countries contributed nearly two-thirds of the global total.
Under the TB Mukt Bharat Abhiyaan, authorities screened over 250 million people between December 2024 and November 2026, identifying 4.86 million new cases including 1.49 million asymptomatic patients. A TB prevalence survey by ICMR-NIRT in 2025 is under technical review, after which the WHO will publish an updated country profile for India.
Update, 12 November 2026: Nagaland Tribune now also reports the story, confirming the 38% mortality reduction and 94% treatment success rate. It adds that 25 crore people were screened between 7 December 2024 and 8 November 2026, with 48.64 lakh new TB cases identified, including 14.97 lakh asymptomatic cases, detailed figures consistent with the ministry data previously reported.
All four outlets cover the WHO report with near-identical wire copy, each leading with the 38% mortality drop and 94% treatment success rate. Hindustan Times and The Hindu devote space to global context, incidence rate, MDR-TB crisis, and catastrophic costs, while Livemint and Nagaland Tribune foreground domestic programme details: AI chest X-rays, the TB Mukt Bharat Abhiyaan’s 250-million screening figure, and 67,933 TB-free Panchayats. The uniform core data and the absence of any critical framing produce straight reporting. The balanced reading is that the coverage confirms India’s faster-than-global mortality decline and a treatment success benchmark, with no outlet challenging the government’s claims or questioning the screening campaign’s cost or reach. The next milestone is the WHO’s updated India country profile after the ICMR-NIRT prevalence survey completes technical review.
Coverage: 4 sources, 1 pro-government, 3 neutral
Sources (4): hindustantimes.com (neutral report), thehindu.com (neutral report), livemint.com (pro government), nagalandtribune.in (neutral report)
This brief was synthesised by AI from the 4 sources linked above, so one read covers every framing they carry. Methodology and corrections.